Can inhibiting insulin/IGF signaling with dietary carbohydrate restriction play a role in treatment/prevention of cancers?


Background Hyperinsulinemia, hyperglycemia, and obesity have been identified as risk factors for a variety of cancers [1]. Insulin inhibition (INSINH) can potentially limit cancer growth by factors including ketosis [2], and apoptosis secondary to fatty acid synthase inhibition [3] as well as intracellular potassium depletion [4]. Furthermore, dysregulation… (More)


  • Presentations referencing similar topics